中文 | English
Return
Total: 2407 , 1/241
Show Home Prev Next End page: GO
Author:( Bo FENG)

1.DPP-4 inhibitors and glucose homeostasis - From cell to bedside

Bo FENG

Chinese Journal of Endocrinology and Metabolism 2012;28(6):525-526

3.Segmental splenectomy, the first choice for treatment of splenic benign tumor

Bo HUANG ; Bianxi FENG

Chinese Journal of Hepatobiliary Surgery 2010;16(6):410-412

4.Liraglutide alleviates arteriosclerotic lesions and inhibits receptor for advanced glycation end-product expression in diabetic ApoE-/- mice

Peicheng LI ; Bo FENG

Chinese Journal of Endocrinology and Metabolism 2016;32(8):680-684

5.Diagnosis and interventional treatment for diabetic peripheral vascular disease

Maoquan LI ; Bo FENG

Journal of Interventional Radiology 2006;0(07):-

6.Relationships among measures of gait recovery and community integration index in people with brain injury

Bo FENG ; Wei XU

Chinese Journal of Primary Medicine and Pharmacy 2015;(14):2203-2205

7.An clinical analysis of gastrointestinal stromal tumors

Huiqin SHEN ; Bo FENG

Chinese Journal of General Surgery 2017;32(7):553-556

8.The influence of continuous quality improvement on nutritional status and renal function and low protein diet adherence in patients with chronic kidney disease

Sue CHEN ; Bo FENG

Journal of Endocrine Surgery 2014;(2):167-169

9.Changes of arterial blood pressure variability and baroreflex sensitivity in diabetic patients

Bo FENG ; Yafang NI

Chinese Journal of Endocrinology and Metabolism 2001;0(05):-

10.Simultaneous Determination of 6 Kinds of Components in Longze Xiongdan Capsules by HPLC

Chengyi HAO ; Bo FENG

China Pharmacy 2017;28(9):1246-1249

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2407 , 1/241 Show Home Prev Next End page: GO